首页 > 市场调查报告书 > 製药

疼痛

市场调查报告书

商品编码

1590312

传统和替代疼痛治疗的全球市场

Conventional and Alternative Pain Treatment Markets

出版日期: 2024年11月13日 | 出版商:

BCC Research | 英文 173 Pages | 订单完成后即时交付

价格

简介目录图表

全球传统和替代疼痛治疗市场规模预计将从 2024 年的 962 亿美元增长到 2029年终的1,442 亿美元，预测期内复合年增长率为 8.4%。

药品/药物治疗产业预计将从 2024 年的 615 亿美元成长到 2029年终的963 亿美元，复合年增长率为 9.4%。设备产业预计将从 2024 年的 347 亿美元成长到 2029年终的479 亿美元，复合年增长率为 6.7%。

该报告研究了全球传统和替代疼痛治疗市场，并提供市场概况、市场影响因素和市场机会分析、法律制度、新兴技术和技术发展趋势、市场规模趋势和预测，我们按不同分类和地区编制了详细分析、竞争状况、主要企业简介等。

市场驱动因素
人口老化加剧
扩大人工智慧在医疗设备中的集成
慢性病发生率上升
增加解决慢性疼痛的公共卫生项目
非药物治疗的进展
市场限制因素
医疗设备设计失败
供应链问题和品质问题
市场机会
扩大穿戴式装置的使用
传统和替代疼痛治疗的技术开发
未来的趋势和可能性

第四章新兴科技与发展

再生医学
再生医学疼痛管理的好处
民兵治疗
週边神经刺激（PNS）
VIA椎间盘治疗
其他技术
穿戴式装置和生物回馈疗法
虚拟实境（VR）治疗
人工智慧在疼痛预测的应用
疼痛管理临床试验
传统疼痛治疗和替代治疗方法的发展趋势

第五章市场区隔分析

细分细分
市场区隔：按疼痛管理类型
市场规模/预测
药品/药物治疗
市场规模/预测
非麻醉性止痛药
医用大麻
麻醉止痛药
偏头痛药物
中枢神经系统（CNS）治疗
麻醉剂
其他类
装置
市场规模/预测
脊椎刺激器
电疗/肌肉刺激
其他设备
市场区隔：按应用
市场规模/预测
整形外科和肌肉骨骼疼痛
市场规模/预测
一般广谱疼痛管理
市场规模/预测
手术疼痛管理
市场规模/预测
偏头痛
市场规模/预测
神经病变疼痛
市场规模/预测
癌症痛
市场规模/预测
纤维肌痛
市场规模/预测
其他类型的疼痛
市场规模/预测
地域分布
市场区隔：按地区
市场规模/预测
北美洲
市场规模/预测
美国
加拿大
墨西哥
欧洲
市场规模/预测
德国
法国
英国
义大利
西班牙
欧洲其他地区
亚太地区
市场规模/预测
中国
日本
印度
澳洲和纽西兰
亚太地区其他地区
拉丁美洲
市场规模/预测
巴西
阿根廷
其他拉丁美洲
中东/非洲
市场规模/预测
南非
海湾合作委员会国家
其他中东/非洲

第六章竞争讯息

世界市场和主要企业分析
协议/合作/伙伴关係
2023 年设备核准

第 7 章永续性

ESG 在传统和替代疼痛治疗行业中的重要性
ESG在疼痛治疗医疗设备业的实践
环境绩效
社会表现
管治绩效
ESG排名
BCC的意见

第8章附录

调查方法
参考
公司简介
ABBOTT
ABBVIE INC.
AMGEN INC.
BAXTER
BAYER AG
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BOSTON SCIENTIFIC CORP.
GSK PLC
JOHNSON & JOHNSON SERVICES INC.
LILLY
MEDTRONIC
MERCK & CO. INC.
NOVARTIS AG
PFIZER INC.
TEVA PHARMACEUTICAL INDUSTRIES LTD.

简介目录图表

Product Code: HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

The pharmaceuticals/drug therapy segment of conventional and alternative pain treatment market is expected to grow from $61.5 billion in 2024 and is projected to reach $96.3 billion by the end of 2029, at a CAGR of 9.4% during the forecast period of 2024 to 2029.

The devices segment of conventional and alternative pain treatment market is expected to grow from $34.7 billion in 2024 and is projected to reach $47.9 billion by the end of 2029, at a CAGR of 6.7% during the forecast period of 2024 to 2029.

Report Scope

This report covers the conventional and alternative pain treatments used by patients with chronic or acute pain. It provides the current and future market potential of conventional and alternative pain treatments and includes a detailed analysis of the competitive environment. The report covers the drivers, restraints and opportunities in the market; surveys the prevalence of or incidence of chronic diseases; and highlights emerging technologies for alternative treatment procedures. It includes market projections for 2029 and provides the market shares of key players.

In this analysis, the conventional and alternative pain treatment market is segmented based on pain management type into pharmaceuticals/drug therapy and devices. The pharmaceuticals/drug therapy segment is further segmented into non-narcotic analgesics, medical cannabis, narcotic analgesics, antimigraine agents, central nervous system (CNS) treatments, anesthetics, and other classes of pharmaceutical drug therapy. The devices segment of the conventional and alternative pain treatment market is further segmented into spine stimulators, electrotherapy/muscle stimulation, and other devices. Based on application, the overall conventional and alternative pain treatment market is segmented into orthopedic and musculoskeletal pain, general and broad pain management, surgical pain management, migraine/headache pain, neuropathic pain, cancer pain, fibromyalgia pain, and other pain types.

The overall conventional and alternative pain treatment market has also been segmented by geography into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa (MEA). Each regional analysis covers the region's leading countries, namely, the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico and GCC countries. Market data is provided for 2023, which serves as the base year; estimates are given for 2024 and forecast values for 2029.

Report Includes

48 data tables and 56 additional tables
Analysis of the global market for conventional and alternative pain treatments
Analyses of global market trends, with market revenue data from 2012-2023, estimates for 2024, and projected CAGRs through 2029
Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by pain management type, application and region
Facts and figures pertaining to the market dynamics, technological advances, regulations, and the influence of macroeconomic factors
A Porter's Five Forces analysis, a global supply chain analysis and a SWOT analysis
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
A look at recent patent grants
Analysis of the industry structure and competitive landscape, including company market shares, strategic alliances, M&A activity and venture funding outlook
Profiles of market leaders, including Medtronic, Abbott, GSK, Pfizer Inc., and Johnson & Johnson

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview of Types of Pain and Its Treatment

Introduction
The Perception of Pain
How Pain is Treated
Pain Management Techniques: Electrical Stimulation
Pain Management Procedures
Alternative Methods of Pain Management
Growing Trend in Cannabis Treatment for Pain
Treatment Using Alternatives for Chronic Pain

Chapter 3 Market Dynamics

Introduction
Market Drivers
Rise in the Aging Population
Increasing Integration of Artificial Intelligence in Medical Devices
Rising Incidence of Chronic Diseases
Growth of Public Health Programs That Address Chronic Pain
Improvement in the Non-Drug Techniques
Market Restraints
Failure in Medical Device Designs
Supply Chain Issues and Quality Concerns
Market Opportunities
Expanding Usage of Wearable Devices
Technological Development for Conventional and Alternative Pain Treatment
Future Trends and Possibilities

Chapter 4 Emerging Technologies and Developments

Introduction
Regenerative Medicine
Advantages of Regenerative Pain Management
Minuteman Procedure
Peripheral Nerve Stimulation (PNS)
VIA Disc Treatment
Other Technologies
Wearable Devices and Biofeedback
Virtual Reality (VR) Therapy
Artificial Intelligence (AI) in Pain Prediction
Pain Management Clinical Trials
Trends in Development of Conventional and Alternative Pain Treatment

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown
Market Breakdown by Pain Management Type
Market Size and Forecast
Pharmaceuticals/Drug Therapy
Market Size and Forecast
Non-Narcotic Analgesics
Medical Cannabis
Narcotic Analgesics
Antimigraine Agents
Central Nervous System (CNS) Treatments
Anesthetics
Other Classes
Devices
Market Size and Forecast
Spine Stimulators
Electrotherapy/Muscle Stimulation
Other Devices
Market Breakdown by Application
Market Size and Forecast
Orthopedic and Musculoskeletal Pain
Market Size and Forecast
General and Broad Pain Management
Market Size and Forecast
Surgical Pain Management
Market Size and Forecast
Migraine/Headache
Market Size and Forecast
Neuropathic Pain
Market Size and Forecast
Cancer Pain
Market Size and Forecast
Fibromyalgia Pain
Market Size and Forecast
Other Pain Types
Market Size and Forecast
Geographical Breakdown
Market Analysis by Region
Market Size and Forecast
North America
Market Size and Forecast
U.S.
Canada
Mexico
Europe
Market Size and Forecast
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Market Size and Forecast
China
Japan
India
Australia and New Zealand
Rest of Asia-Pacific
Latin America
Market Size and Forecast
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Market Size and Forecast
South Africa
GCC Countries
Rest of the Middle East & Africa

Chapter 6 Competitive Intelligence

Introduction
Global Analysis of the Market and Its Leading Players
Agreements, Collaborations and Partnerships
2023 Device Approvals

Chapter 7 Sustainability

Importance of ESG in the Conventional and Alternative Pain Treatment Industry
ESG Practices in the Pain Treatment Medical Device Industry
Environmental Performance
Social Performance
Governance Performance
ESG Ranking
BCC Research Viewpoint

Chapter 8 Appendix

Research Methodology
References
Company Profiles
ABBOTT
ABBVIE INC.
AMGEN INC.
BAXTER
BAYER AG
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BOSTON SCIENTIFIC CORP.
GSK PLC
JOHNSON & JOHNSON SERVICES INC.
LILLY
MEDTRONIC
MERCK & CO. INC.
NOVARTIS AG
PFIZER INC.
TEVA PHARMACEUTICAL INDUSTRIES LTD.

简介目录图表

List of Tables

Summary Table : Global Conventional and Alternative Pain Treatment Market, by Pain Management Type, Through 2029
Table 1 : Most Common Long-Term Health Conditions in Australia, by Age Group, 2022
Table 2 : Clinical Trials for Pain Management at UCSF, 2024
Table 3 : Additional Clinical Trials for Pain Management, 2024
Table 4 : Complementary and Alternative Medicines, by Types
Table 5 : Global Conventional and Alternative Pain Treatment Market, by Pain Management Type, Through 2029
Table 6 : Global Conventional and Alternative Pain Treatment Market for Pharmaceuticals/Drug Therapy, by Region, Through 2029
Table 7 : Global Conventional and Alternative Pain Treatment Market for Pharmaceuticals/Drug Therapy, by Type, Through 2029
Table 8 : List of NSAIDs
Table 9 : Global Non-Narcotic Analgesics Market, by Region, Through 2029
Table 10 : Global Medical Cannabis Market, by Region, Through 2029
Table 11 : Global Narcotic Analgesics Market, by Region, Through 2029
Table 12 : Global Antimigraine Agents Market, by Region, Through 2029
Table 13 : Global CNS Treatments Market, by Region, Through 2029
Table 14 : Global Anesthetics Market, by Region, Through 2029
Table 15 : Global Other Classes Market of Pharmaceutical Drug Therapy, by Region, Through 2029
Table 16 : Global Conventional and Alternative Pain Treatment Market for Devices, by Type, Through 2029
Table 17 : Global Conventional and Alternative Pain Treatment Market for Devices, by Region, Through 2029
Table 18 : Global Spine Stimulators Market, by Region, Through 2029
Table 19 : Global Electrotherapy/Muscle Stimulation Market, by Region, Through 2029
Table 20 : Global Other Devices Market, by Region, Through 2029
Table 21 : Global Conventional and Alternative Pain Treatment Market, by Application, Through 2029
Table 22 : Global Orthopedic and Musculoskeletal Pain Application Market, by Region, Through 2029
Table 23 : Global General and Broad Pain Management Application Market, by Region, Through 2029
Table 24 : Global Surgical Pain Management Application Market, by Region, Through 2029
Table 25 : Global Migraine/Headache Application Market, by Region, Through 2029
Table 26 : Global Neuropathic Pain Application Market, by Region, Through 2029
Table 27 : Cancer Pain Medication
Table 28 : Global Cancer Pain Application Market, by Region, Through 2029
Table 29 : Global Fibromyalgia Pain Application Market, by Region, Through 2029
Table 30 : Global Other Pain Applications Market, by Region, Through 2029
Table 31 : Global Conventional and Alternative Pain Treatment Market, by Region, Through 2029
Table 32 : North American Conventional and Alternative Pain Treatment Market, by Country, Through 2029
Table 33 : European Conventional and Alternative Pain Treatment Market, by Country, Through 2029
Table 34 : Chronic Pain Rates, by Population and Percentage Affected, 2029
Table 35 : Asia-Pacific Conventional and Alternative Pain Treatment Market, by Country, Through 2029
Table 36 : Latin American Countries that Participated in the FEDELAT survey, 2017-2022
Table 37 : Latin American Conventional and Alternative Pain Treatment Market, by Country, Through 2029
Table 38 : Middle Eastern & African Conventional and Alternative Pain Treatment Market, by Sub-Region, Through 2029
Table 39 : Medical Devices Cleared or Approved by FDA, 2023
Table 40 : ESG Practices: Environmental Performance
Table 41 : ESG Practices: Social Performance
Table 42 : ESG Practices: Governance Performance
Table 43 : ESG Rankings for Major Medical Device Companies, 2023 and 2024*
Table 44 : Abbott: Company Snapshot
Table 45 : Abbott: Financial Performance, 2022 and 2023
Table 46 : Abbott: Product Portfolio
Table 47 : Abbott: News/Key Developments, 2022 and 2023
Table 48 : AbbVie Inc.: Company Snapshot
Table 49 : AbbVie Inc.: Financial Performance, 2022 and 2023
Table 50 : AbbVie Inc.: Product Portfolio
Table 51 : AbbVie Inc.: News/Key Developments, 2024
Table 52 : Amgen Inc.: Company Snapshot
Table 53 : Amgen Inc.: Financial Performance, 2022 and 2023
Table 54 : Amgen Inc.: Product Portfolio
Table 55 : Amgen Inc.: News/Key Developments, 2022 and 2023
Table 56 : Baxter: Company Snapshot
Table 57 : Baxter: Financial Performance, 2022 and 2023
Table 58 : Baxter: Product Portfolio
Table 59 : Baxter: News/Key Developments, 2021-2024
Table 60 : Bayer AG: Company Snapshot
Table 61 : Bayer AG: Financial Performance, 2022 and 2023
Table 62 : Bayer AG: Product Portfolio
Table 63 : Bayer AG: News/Key Developments, 2023
Table 64 : Boehringer Ingelheim International GmbH: Company Snapshot
Table 65 : Boehringer Ingelheim International GmbH: Financial Performance, 2022 and 2023
Table 66 : Boehringer Ingelheim International GmbH: Product Portfolio
Table 67 : Boehringer Ingelheim International GmbH: News/Key Developments, 2022-2024
Table 68 : Boston Scientific Corp.: Company Snapshot
Table 69 : Boston Scientific Corp.: Financial Performance, 2022 and 2023
Table 70 : Boston Scientific Corp.: Product Portfolio
Table 71 : Boston Scientific Corp.: News/Key Developments, 2023 and 2024
Table 72 : GSK Plc: Company Snapshot
Table 73 : GSK Plc: Financial Performance, 2022 and 2023
Table 74 : GSK Plc: Products Portfolio
Table 75 : GSK Plc.: News/Key Developments, 2021 and 2022
Table 76 : Johnson and Johnson Services Inc.: Company Snapshot
Table 77 : Johnson and Johnson Services Inc.: Financial Performance, 2022 and 2023
Table 78 : Johnson and Johnson Services Inc.: Product Portfolio
Table 79 : Johnson and Johnson Services Inc.: News/Key Developments, 2021-2024
Table 80 : Lilly: Company Snapshot
Table 81 : Lilly: Financial Performance, 2022 and 2023
Table 82 : Lilly: Product Portfolio
Table 83 : Lilly: News/Key Developments, 2021 and 2022
Table 84 : Medtronic: Company Snapshot
Table 85 : Medtronic: Financial Performance, 2022 and 2023
Table 86 : Medtronic: Product Portfolio
Table 87 : Medtronic: News/Key Developments, 2022-2024
Table 88 : Merck & Co. Inc.: Company Snapshot
Table 89 : Merck & Co. Inc.: Financial Performance, 2022 and 2023
Table 90 : Merck & Co. Inc.: Product Portfolio
Table 91 : Merck & Co. Inc.: News/Key Developments, 2022-2024
Table 92 : Novartis AG: Company Snapshot
Table 93 : Novartis AG: Financial Performance, 2022 and 2023
Table 94 : Novartis AG: Product Portfolio
Table 95 : Novartis AG: News/Key Developments, 2022 and 2023
Table 96 : Pfizer Inc.: Company Snapshot
Table 97 : Pfizer Inc.: Financial Performance, 2022 and 2023
Table 98 : Pfizer Inc.: Product Portfolio
Table 99 : Pfizer Inc.: News/Key Developments, 2021-2024
Table 100 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 101 : Teva Pharmaceutical Industries Ltd.: Financial Performance, 2022 and 2023
Table 102 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 103 : Teva Pharmaceutical Industries Ltd.: News/Key Developments, 2021-2024

List of Figures

Summary Figure : Global Conventional and Alternative Pain Treatment Market Shares, by Pain Management Type, 2023
Figure 1 : Pain Management Treatments
Figure 2 : Market Dynamics
Figure 3 : Global Projected Shares of Elderly Population (Aged 65 Years and Older), by Region, 2050
Figure 4 : Future Trends for Pain Management
Figure 5 : Types of Pain Management Techniques and Their Usage
Figure 6 : Most Popular Forms of Alternative Medicines and Therapies in the U.S., 2022
Figure 7 : Global Conventional and Alternative Pain Treatment Market Shares, by Pain Management Type, 2023
Figure 8 : Global Conventional and Alternative Pain Treatment Market Shares for Pharmaceuticals/Drug Therapy, by Type, 2023
Figure 9 : Global Conventional and Alternative Pain Treatment Market Shares for Device, by Type, 2023
Figure 10 : Global Conventional and Alternative Pain Treatment Market Shares, by Application, 2023
Figure 11 : Projections of Osteoarthritis, 2050
Figure 12 : Global Conventional and Alternative Pain Treatment Market Shares, by Region, 2023
Figure 13 : North American Conventional and Alternative Pain Treatment Market Shares, by Pain Management Type, 2023
Figure 14 : North American Conventional and Alternative Pain Treatment Market Shares for Pharmaceuticals/Drug Therapy, by Type, 2023
Figure 15 : North American Conventional and Alternative Pain Treatment Market Shares for Devices, by Type, 2023
Figure 16 : North American Conventional and Alternative Pain Treatment Market Shares, by Application, 2023
Figure 17 : North American Conventional and Alternative Pain Treatment Market Shares, by Country, 2023
Figure 18 : European Conventional and Alternative Pain Treatment Market Shares, by Pain Management Type, 2023
Figure 19 : European Conventional and Alternative Pain Treatment Market Shares for Pharmaceuticals/Drug Therapy, by Type, 2023
Figure 20 : European Conventional and Alternative Pain Treatment Market Shares for Devices, by Type, 2023
Figure 21 : European Conventional and Alternative Pain Treatment Market Shares, by Application, 2023
Figure 22 : European Conventional and Alternative Pain Treatment Market Shares, by Country, 2023
Figure 23 : Spanish Spending Across All Healthcare Categories
Figure 24 : Asia-Pacific Conventional and Alternative Pain Treatment Market Shares, by Pain Management Type, 2023
Figure 25 : Asia-Pacific Conventional and Alternative Pain Treatment Market Shares for Pharmaceuticals/Drug Therapy, by Type, 2023
Figure 26 : Asia-Pacific Conventional and Alternative Pain Treatment Market Shares for Devices, by Type, 2023
Figure 27 : Asia-Pacific Conventional and Alternative Pain Treatment Market Shares, by Application, 2023
Figure 28 : Asia-Pacific Conventional and Alternative Pain Treatment Market Shares, by Country, 2023
Figure 29 : Latin American Conventional and Alternative Pain Treatment Market Shares, by Pain Management Type, 2023
Figure 30 : Latin American Conventional and Alternative Pain Treatment Market Shares for Pharmaceuticals/Drug Therapy, by Type, 2023
Figure 31 : Latin American Conventional and Alternative Pain Treatment Market Shares for Devices, by Type, 2023
Figure 32 : Latin American Conventional and Alternative Pain Treatment Market Shares, by Application, 2023
Figure 33 : Latin American Conventional and Alternative Pain Treatment Market Shares, by Country, 2023
Figure 34 : Middle Eastern & African Conventional and Alternative Pain Treatment Market Shares, by Pain Management Type, 2023
Figure 35 : Middle Eastern & African Conventional and Alternative Pain Treatment Market Shares for Pharmaceuticals/Drug Therapy, by Type, 2023
Figure 36 : Middle Eastern & African Conventional and Alternative Pain Treatment Market Shares for Devices, by Type, 2023
Figure 37 : Middle Eastern & African Conventional and Alternative Pain Treatment Market Shares, by Application, 2023
Figure 38 : Middle Eastern & African Conventional and Alternative Pain Treatment Market Shares, by Sub-Region, 2023
Figure 39 : Leading Players in the Conventional and Alternative Pain Treatment Market, 2023
Figure 40 : Snapshot: Key ESG Trends in the Conventional and Alternative Pain Treatment Industry
Figure 41 : Viewpoints on Sustainable Medical Devices
Figure 42 : Abbott: Revenue Shares, by Business Unit, 2023
Figure 43 : Abbott: Revenue Shares, by Country/Region, 2023
Figure 44 : AbbVie Inc.: Revenue Shares, by Business Unit, 2023
Figure 45 : AbbVie Inc.: Revenue Shares, by Country/Region, 2023
Figure 46 : Amgen Inc.: Revenue Shares, by Business Unit, 2023
Figure 47 : Amgen Inc.: Revenue Shares, by Country/Region, 2023
Figure 48 : Baxter.: Revenue Shares, by Business Unit, 2023
Figure 49 : Baxter: Revenue Shares, by Country/Region, 2023
Figure 50 : Bayer AG: Revenue Shares, by Country/Region, 2023
Figure 51 : Bayer AG: Revenue Shares, by Business Unit, 2023
Figure 52 : Boehringer Ingelheim International GmbH: Revenue Shares, by Business Unit, 2023
Figure 53 : Boehringer Ingelheim International GmbH: Revenue Shares, by Country/Region, 2023
Figure 54 : Boston Scientific Corp.: Revenue Shares, by Business Unit, 2023
Figure 55 : Boston Scientific Corp.: Revenue Shares, by Country/Region, 2023
Figure 56 : GSK Plc: Revenue Shares, by Business Unit, 2023
Figure 57 : GSK Plc: Revenue Shares, by Country/Region, 2023
Figure 58 : Johnson and Johnson Services Inc.: Revenue Shares, by Business Unit, 2023
Figure 59 : Johnson and Johnson Services Inc.: Revenue Shares, by Country/Region, 2023
Figure 60 : Lilly: Revenue Shares, by Business Unit, 2023
Figure 61 : Lilly: Revenue Shares, by Country/Region, 2023
Figure 62 : Medtronic.: Revenue Shares, by Business Unit, 2023
Figure 63 : Medtronic: Revenue Shares, by Country/Region, 2023
Figure 64 : Merck & Co. Inc.: Revenue Shares, by Business Unit, 2023
Figure 65 : Merck & Co. Inc.: Revenue Shares, by Country/Region, 2023
Figure 66 : Novartis AG: Revenue Shares, by Business Unit, 2023
Figure 67 : Novartis AG: Revenue Shares, by Country/Region, 2023
Figure 68 : Pfizer Inc.: Revenue Shares, by Business Unit, 2023
Figure 69 : Pfizer Inc.: Revenue Shares, by Country/Region, 2023
Figure 70 : Teva Pharmaceutical Industries Ltd.: Revenue Shares, Business Unit, 2023
Figure 71 : Teva Pharmaceutical Industries Ltd.: Revenue Shares, by Country/Region, 2023